Frankincense: Art and Science of Resin

Abstract: Frankincense, derived from the resin of Boswellia species, has been valued for millennia across diverse cultures for its aromatic, medicinal, and economic significance. This review provides an in-depth analysis of frankincense, encompassing its historical development, geographical distribution, and trade dynamics. The paper examines the economic aspects of frankincense production, including its impact on local economies and global markets. Detailed attention is given to the plantation and harvesting practices, production statistics, and the chemical composition of frankincense. Various types and colours of frankincense are discussed, along with quality assessment criteria. The review explores the diverse properties and applications of frankincense products, including their benefits and potential side effects. Additionally, it addresses sustainable harvesting practices, conservation efforts, and regulatory considerations. The paper concludes with a summary of recent scientific research, current challenges in the industry, and future directions for exploration and improvement.

Frankincense, History and geography, Trade and economy, Agriculture, Chemistry, Sustainability, Regulatory aspects

1. Ammon, H. P. (2002). Boswellic acids (components of frankincense) as the active principle in treatment of chronic inflammatory diseases. Wiener Medizinische Wochenschrift (1946), 152(15-16), 373-378. [Google Scholar] [Crossref]

2. Ernst, E. (2008). Frankincense: systematic review. Bmj, 337. [Google Scholar] [Crossref]

3. Mertens, M., Buettner, A., & Kirchhoff, E. (2009). The volatile constituents of frankincense–a review. Flavour and Fragrance Journal, 24(6), 279-300. [Google Scholar] [Crossref]

4. Al-Harrasi, A., Khan, A. L., Asaf, S., Al-Rawahi, A., Al-Harrasi, A., Khan, A. L., ... & Al-Rawahi, A. (2019). Frankincense and human civilization: A historical review. Biology of Genus Boswellia, 1-9. [Google Scholar] [Crossref]

5. Bongers, F., Groenendijk, P., Bekele, T., Birhane, E., Damtew, A., Decuyper, M., ... & Zuidema, P. A. (2019). Frankincense in peril. Nature Sustainability, 2(7), 602-610. [Google Scholar] [Crossref]

6. Khalifa, S. A., Kotb, S. M., El-Seedi, S. H., Nahar, L., Sarker, S. D., Guo, Z., ... & El-Seedi, H. R. (2023). Frankincense of Boswellia sacra: Traditional and modern applied uses, pharmacological activities, and clinical trials. Industrial Crops and Products, 203, 117106. [Google Scholar] [Crossref]

7. Hussain, H., Al-Harrasi, A., & Green, I. R. (2016). Frankincense (Boswellia) Oils. In Essential Oils in Food Preservation, Flavor and Safety (pp. 431-440). Academic Press. [Google Scholar] [Crossref]

8. Yadav, S., & Gupta, S. K. (2018). A systematic review on frankincense (Boswellia species). Intern. J. Innovative Res. Technol., 5(5), 212-224. [Google Scholar] [Crossref]

9. Badria, F. A. (2015). Frankincense (Heaven’s Gift) - chemistry, biology, and clinical applications. Evidence-based Strategies in Herbal Medicine, Psychiatric Disorders and Emergency Medicine, 1-22. [Google Scholar] [Crossref]

10. Abbood, S. M., Kadhim, S. M., Al-Ethari, A. Y. H., AL-Qaisia, Z. H., & Mohammed, M. T. (2022). Review on Frankincense Essential Oils: Chemical Composition and Biological activities. (Humanities, social and applied sciences) Misan Journal of Academic Studies, 21(44), 332-345. [Google Scholar] [Crossref]

11. Börner, F., Werner, M., Ertelt, J., Meins, J., Abdel-Tawab, M., & Werz, O. (2021). Analysis of boswellic acid contents and related pharmacological activities of frankincense-based remedies that modulate inflammation. Pharmaceuticals, 14(7), 660. [Google Scholar] [Crossref]

12. Sabo, P., Salako, K. V., Stephen, J., Glèlè Kakaï, R., & Ouédraogo, A. (2022). Current knowledge and conservation perspectives of Boswellia dalzielii Hutch., an African frankincense tree. Genetic Resources and Crop Evolution, 69(7), 2261-2278. [Google Scholar] [Crossref]

13. Maksimović, Z. (2021). On Frankincense. Archives of Pharmacy, 71(Notebook 1), 1-21. [Google Scholar] [Crossref]

14. Lu, Y., Luan, H., Peng, C., Ma, J., Li, Z., Hu, Y., & Song, X. (2024). Application of network pharmacology and dock of molecules on the exploration of the mechanism of frankincense-myrrh for lumbar intervertebral disc degeneration: A review. Medicine, 103(29), e38953. [Google Scholar] [Crossref]

15. Cao, B., Wei, X. C., Xu, X. R., Zhang, H. Z., Luo, C. H., Feng, B., ... & Zhang, D. K. (2019). Seeing the unseen of the combination of two natural resins, frankincense and myrrh: Changes in chemical constituents and pharmacological activities. Molecules, 24(17), 3076. [Google Scholar] [Crossref]

16. Hamidpour, S. H., Hamidpour, M., Shahlari, M., & Hamidpour, R. (2015). Chemistry, pharmacology and medicinal property of frankincense (Boswellia species): from the selection of traditional applications to the novel phytotherapy for the prevention and treatment of serious diseases. Global Journal of Medical Research, 15, 1-9. [Google Scholar] [Crossref]

17. Efferth, T., & Oesch, F. (2022, May). Anti-inflammatory and anti-cancer activities of frankincense: Targets, treatments and toxicities. In Seminars in cancer biology (Vol. 80, pp. 39-57). Academic Press. [Google Scholar] [Crossref]

18. Almeida-da-Silva, C. L. C., Sivakumar, N., Asadi, H., Chang-Chien, A., Qoronfleh, M. W., Ojcius, D. M., & Essa, M. M. (2022). Effects of frankincense compounds on infection, inflammation, and oral health. Molecules, 27(13), 4174. [Google Scholar] [Crossref]

19. Brendler, T., Brinckmann, J. A., & Schippmann, U. (2018). Sustainable supply, a foundation for natural product development: The case of Indian frankincense (Boswellia serrata Roxb. ex Colebr.). Journal of ethnopharmacology, 225, 279-286. [Google Scholar] [Crossref]

20. Buch, R. M., Carlson, R. E., & von Fraunhofer, J. A. (2022). Frankincense: an ancient oil in the modern world. Journal of Essential Oil Research, 34(4), 303-312. [Google Scholar] [Crossref]

21. Al-Yasiry, A. R. M., & Kiczorowska, B. (2016). Frankincense–therapeutic properties. Advances in Hygiene and Experimental Medicine, 70, 380-391. [Google Scholar] [Crossref]

22. Hussain, H., Rashan, L., Hassan, U., Abbas, M., Hakkim, F. L., & Green, I. R. (2022). Frankincense diterpenes as a bio-source for drug discovery. Expert Opinion on Drug Discovery, 17(5), 513-529. [Google Scholar] [Crossref]

23. Calabrese, V., Osakabe, N., Khan, F., Wenzel, U., Modafferi, S., Nicolosi, L., ... & Rashan, L. (2024). Frankincense: A neuronutrient to approach Parkinson’s disease treatment. Open Medicine, 19(1), 20240988. [Google Scholar] [Crossref]

24. Al‐Harrasi, A., Hussain, H., Csuk, R., & Khan, H. Y. (2018). Frankincense in modern medicine. Chemistry and Bioactivity of Boswellic acids and other terpenoids of the genus Boswellia, 127-136. [Google Scholar] [Crossref]

25. Noroozi, S., Khadem Haghighian, H., Abbasi, M., Javadi, M., & Goodarzi, S. (2018). A review of the therapeutic effects of frankincense. Journal of Inflammatory Diseases, 22(1), 70-81. [Google Scholar] [Crossref]

26. Morikawa, T., Matsuda, H., & Yoshikawa, M. (2017). A review of anti-inflammatory terpenoids from the incense gum resins frankincense and myrrh. Journal of oleo science, 66(8), 805-814. [Google Scholar] [Crossref]

27. Hamidpour, R., Hamidpour, S., Hamidpour, M., & Shahlari, M. (2013). Frankincense (Boswellia Species): From the selection of traditional applications to the novel phytotherapy for the prevention and treatment of serious diseases. Journal of traditional and complementary medicine, 3(4), 221-226. [Google Scholar] [Crossref]

28. Khajehdehi, M., Khalaj‐Kondori, M., & Baradaran, B. (2022). Molecular evidences on anti‐inflammatory, anticancer, and memory‐boosting effects of frankincense. Phytotherapy Research, 36(3), 1194-1215. [Google Scholar] [Crossref]

29. Cock, I. E., Akpe, V., & Cheesman, M. J. Frankincense (Boswellia sacra Flueck.) and its usage in the Middle East: molecular, cellular, and biomedical aspects. Ancient and Traditional Foods, Plants, Herbs and Spices used in the Middle East, 157-177. [Google Scholar] [Crossref]

30. Zaker, R., & Beheshti, S. (2021). An updated review of the therapeutic anti-inflammatory effects of frankincense. Future Natural Products, 6(1), 28-55. [Google Scholar] [Crossref]

31. Al-Balushi, R. A., Haque, A., Saeed, M., Al-Harthy, T., Al-Hinaai, M., & Al-Hashmi, S. (2023). Unlocking the Anticancer Potential of Frankincense Essential Oils (FEOs) Through Nanotechnology: A Review. Molecular Biotechnology, 1-12. [Google Scholar] [Crossref]

32. Abdelwahab, S. I., Taha, M. M. E., Jerah, A. A., Farasani, A., Abdullah, S. M., Aljahdali, I. A., ... & Babiker, Y. O. H. (2024). Insights into Frankincense and Myrrh Research: A Comprehensive Analytical Study of Patterns and Perspectives. Heliyon. [Google Scholar] [Crossref]

33. Van Beek, G. W. (1960). Frankincense and myrrh. The Biblical Archaeologist, 23(3), 70-95. [Google Scholar] [Crossref]

34. Van Vuuren, S. F., Kamatou, G. P., & Viljoen, A. M. (2010). Volatile composition and antimicrobial activity of twenty commercial frankincense essential oil samples. South African Journal of Botany, 76(4), 686-691. [Google Scholar] [Crossref]

35. Iram, F., Khan, S. A., & Husain, A. (2017). Phytochemistry and potential therapeutic actions of Boswellic acids: A mini-review. Asian Pacific journal of tropical biomedicine, 7(6), 513-523. [Google Scholar] [Crossref]

36. Gebrehiwot, K., Muys, B., Haile, M., & Mitloehner, R. (2003). Introducing Boswellia papyrifera (Del.) Hochst and its non-timber forest product, frankincense. International forestry review, 5(4), 348-353. [Google Scholar] [Crossref]

37. Niebler, J., & Buettner, A. (2016). Frankincense revisited, part I: Comparative analysis of volatiles in commercially relevant Boswellia species. Chemistry & Biodiversity, 13(5), 613-629. [Google Scholar] [Crossref]

38. Miran, M., Amirshahrokhi, K., Ajanii, Y., Zadali, R., Rutter, M. W., Enayati, A., & Movahedzadeh, F. (2022). Taxonomical investigation, chemical composition, traditional use in medicine, and pharmacological activities of Boswellia sacra flueck. Evidence‐Based Complementary and Alternative Medicine, 2022(1), 8779676. [Google Scholar] [Crossref]

39. Stürner, K. H., Stellmann, J. P., Dörr, J., Paul, F., Friede, T., Schammler, S., ... & Heesen, C. (2018). A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial). Journal of Neurology, Neurosurgery & Psychiatry, 89(4), 330-338. [Google Scholar] [Crossref]

40. Lemenith, M., & Teketay, D. (2003). Frankincense and myrrh resources of Ethiopia: II. Medicinal and industrial uses. SINET: Ethiopian Journal of Science, 26(2), 161-172. [Google Scholar] [Crossref]

41. Bansal, N., Mehan, S., Kalra, S., & Khanna, D. (2013). Boswellia serrata-frankincense (A Jesus Gifted Herb); an updated pharmacological profile. Pharmacologia, 4(6), 457-463. [Google Scholar] [Crossref]

42. Okano, S., Honda, Y., Kodama, T., & Kimura, M. (2019). The effects of frankincense essential oil on stress in rats. Journal of Oleo Science, 68(10), 1003-1009. [Google Scholar] [Crossref]

43. Cerutti‐Delasalle, C., Mehiri, M., Cagliero, C., Rubiolo, P., Bicchi, C., Meierhenrich, U. J., & Baldovini, N. (2016). The (+)‐cis‐and (+)‐trans‐Olibanic Acids: Key Odorants of Frankincense. Angewandte Chemie, 128(44), 13923-13927. [Google Scholar] [Crossref]

44. Rashan, L., Hakkim, F. L., Idrees, M., Essa, M. M., Velusamy, T., Al-Baloshi, M., ... & Hasson, S. S. A. A. (2019). Boswellia gum resin and essential oils: Potential health benefits− An evidence based review. International Journal of Nutrition, Pharmacology, Neurological Diseases, 9(2), 53-71. [Google Scholar] [Crossref]

45. Thulin, M. (2020). The Genus Boswellia (Burseraceae): The Frankincense Trees. Acta Universitatis Upsaliensis. [Google Scholar] [Crossref]

46. Wu, Y. R., Xiong, W., Dong, Y. J., Chen, X., Zhong, Y. Y., He, X. L., ... & Zhou, Q. (2024). Chemical Constituents and Pharmacological Properties of Frankincense: Implications for Anticancer Therapy. Chinese Journal of Integrative Medicine, 1-9. [Google Scholar] [Crossref]

47. Satyal, P., & Pappas, R. S. (2016). First reporting on the chemistry and biological activity of a novel Boswellia chemotype: The methoxy alkane frankincense. Glob. J. Sci. Front. Res. B Chem, 16, 1-9. [Google Scholar] [Crossref]

48. Al-Salmi, F. A., Salman, N. S. S. B., Badri, N. A., Othman, F. A. A. B., & Al Salmi, S. A. A comprehensive overview of biochemical and histological inducible alterations from frankincense aqueous extract on Wistar rats. [Google Scholar] [Crossref]

49. Leminih, M., & Teketay, D. (2003). Frankincense and myrrh resources of Ethiopia: I distribution, production, opportunities for dryland development and research needs. SINET: Ethiopian Journal of Science, 26(1), 63-72. [Google Scholar] [Crossref]

50. Ismail, S. M., Aluru, S., Sambasivarao, K. R. S., & Matcha, B. (2014). Antimicrobial activity of frankincense of Boswellia serrata. Int. J. Curr. Microbiol. App. Sci, 3(10), 1095-1101. [Google Scholar] [Crossref]

51. Khan, A. L., Al-Harrasi, A., Wang, J. P., Asaf, S., Riethoven, J. J. M., Shehzad, T., ... & Wang, X. Y. (2022). Genome structure and evolutionary history of frankincense producing Boswellia sacra. Iscience, 25(7). [Google Scholar] [Crossref]

52. Sultan, F. I. (2020). Phytochemical analysis and antibacterial activities of Frankincense of Boswellia serrate. Plant Archives, 20(2), 5219-5226. [Google Scholar] [Crossref]

53. Shen, T., & Lou, H. X. (2008). Bioactive constituents of myrrh and frankincense, two simultaneously prescribed gum resins in Chinese traditional medicine. Chemistry & biodiversity, 5(4), 540-553. [Google Scholar] [Crossref]

54. Mahdian, D., Abbaszadeh-Goudarzi, K., Raoofi, A., Dadashizadeh, G., Abroudi, M., Zarepour, E., & Hosseinzadeh, H. (2020). Effect of Boswellia species on the metabolic syndrome: A review. Iranian Journal of Basic Medical Sciences, 23(11), 1374. [Google Scholar] [Crossref]

55. Almutairi, M. B. F., Alrouji, M., Almuhanna, Y., Asad, M., & Joseph, B. (2022). In-Vitro and In-Vivo Antibacterial Effects of Frankincense Oil and Its Interaction with Some Antibiotics against Multidrug-Resistant Pathogens. Antibiotics, 11(11), 1591. [Google Scholar] [Crossref]

56. Moussaieff, A., & Mechoulam, R. (2009). Boswellia resin: from religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trials. Journal of Pharmacy and Pharmacology, 61(10), 1281-1293. [Google Scholar] [Crossref]

57. Huang, K., Chen, Y., Liang, K., Xu, X., Jiang, J., Liu, M., & Zhou, F. (2022). Review of the chemical composition, pharmacological effects, pharmacokinetics, and quality control of Boswellia carterii. Evidence‐Based Complementary and Alternative Medicine, 2022(1), 6627104. [Google Scholar] [Crossref]

58. Jivad, N., Rafeian, M., & Yarmohammadi, P. (2017). A Clinical Survey Efficacy Of Frankincense In Acute Ischemic Stroke. Advances in Biosciences & Clinical Medicine, 32. [Google Scholar] [Crossref]

59. Su, S., Duan, J., Chen, T., Huang, X., Shang, E., Yu, L., ... & Tang, Y. (2015). Frankincense and myrrh suppress inflammation via regulation of the metabolic profiling and the MAPK signaling pathway. Scientific reports, 5(1), 13668. [Google Scholar] [Crossref]

60. Efferth, T., & Greten, H. J. (2011). Anti-inflammatory and anti-cancer activity of boswellic acids from frankincense (Boswellia serrata Roxb. et Colebr, B. carterii Birdw.). Onco Therapeutics, 2(4). [Google Scholar] [Crossref]

• Exploration of Organizational Culture on Employee Well-Being: A Survey-Based Study on Workplace Culture Dimensions
• Peecheck 2.0: Design and Improvement of Rapid and Low-Cost Urine Analysis Device for Rural Health Care
• Energy Mixed More Fuels with Lower Carbon Contain and Renewable Energy Reduce Carbon Dioxide Emissions: A Review
• Sustainable Economic Growth Through Artificial Intelligence -Driven Tax Frameworks Nexus on Enhancing Business Efficiency and Prosperity; An Appraisal
• Federalism and National Integration in Nigeria: A Study of Selected States in South-South, Nigeria